ValiRx Statistics

Total Valuation

ValiRx has a market cap or net worth of GBP 1.78 million. The enterprise value is 642,576.

Market Cap	1.78M
Enterprise Value	642,576

Important Dates

The last earnings date was Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	n/a

Share Statistics

ValiRx has 374.35 million shares outstanding. The number of shares has increased by 22.67% in one year.

Current Share Class	n/a
Shares Outstanding	374.35M
Shares Change (YoY)	+22.67%
Shares Change (QoQ)	+28.20%
Owned by Insiders (%)	12.22%
Owned by Institutions (%)	66.08%
Float	324.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	185.22
PB Ratio	0.51
P/TBV Ratio	1.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.33
EV / Sales	66.94
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.40

Financial Position

The company has a current ratio of 6.65, with a Debt / Equity ratio of 0.00.

Current Ratio	6.65
Quick Ratio	6.27
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-610.40

Financial Efficiency

Return on equity (ROE) is -55.39% and return on invested capital (ROIC) is -37.24%.

Return on Equity (ROE)	-55.39%
Return on Assets (ROA)	-35.98%
Return on Invested Capital (ROIC)	-37.24%
Return on Capital Employed (ROCE)	-63.66%
Revenue Per Employee	600
Profits Per Employee	-123,324
Employee Count	16
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -85.39% in the last 52 weeks. The beta is 0.10, so ValiRx's price volatility has been lower than the market average.

Beta (5Y)	0.10
52-Week Price Change	-85.39%
50-Day Moving Average	0.56
200-Day Moving Average	1.31
Relative Strength Index (RSI)	34.21
Average Volume (20 Days)	3,277,874

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ValiRx had revenue of GBP 9,600 and -1.97 million in losses. Loss per share was -0.02.

Revenue	9,600
Gross Profit	8,160
Operating Income	-2.24M
Pretax Income	-2.20M
Net Income	-1.97M
EBITDA	-1.97M
EBIT	-2.24M
Loss Per Share	-0.02

Full Income Statement

Balance Sheet

The company has 809,147 in cash and 16,995 in debt, giving a net cash position of 792,152 or 0.00 per share.

Cash & Cash Equivalents	809,147
Total Debt	16,995
Net Cash	792,152
Net Cash Per Share	0.00
Equity (Book Value)	3.50M
Book Value Per Share	0.03
Working Capital	1.02M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.56 million and capital expenditures -30,791, giving a free cash flow of -1.59 million.

Operating Cash Flow	-1.56M
Capital Expenditures	-30,791
Free Cash Flow	-1.59M
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross Margin	85.00%
Operating Margin	-23,284.04%
Pretax Margin	-22,944.16%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ValiRx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.67%
Shareholder Yield	-22.67%
Earnings Yield	-110.97%
FCF Yield	-89.37%

Stock Splits

The last stock split was on April 6, 2020. It was a reverse split with a ratio of 0.008.

Last Split Date	Apr 6, 2020
Split Type	Reverse
Split Ratio	0.008

Scores

ValiRx has an Altman Z-Score of 4.22.

Altman Z-Score	4.22
Piotroski F-Score	n/a